GlassScriptPhysician profile
Stephanie Marshall
NPI 1124002738
$5,337.14
in general payments reported to CMS, 2019-2025
38 companies · $522 in 2025
The $522 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,834 · 2020: $624 · 2021: $452 · 2022: $757 · 2023: $578 · 2024: $571 · 2025: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,670.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,219.48 | 2019-2022 | |
| Amgen INC. | $817.96 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $520.83 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $470.28 | 2021-2025 | Verquvo, Capvaxive, Winrevair |
| Janssen Pharmaceuticals, INC | $403.46 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $241.85 | 2019-2025 | Breztri, Farxiga |
| Sanofi-Aventis U.S. LLC | $151.99 | 2019-2020 | |
| Pfizer INC. | $132.58 | 2019-2024 | |
| Scpharmaceuticals INC. | $117.10 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $115.21 | 2019-2024 | Eliquis, Camzyos |
| Esperion Therapeutics, INC. | $113.10 | 2020-2021 | |
| Novo Nordisk INC | $112.68 | 2022-2025 | Wegovy, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.91 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $90.94 | 2019-2022 | |
| Boston Scientific Corporation | $75.51 | 2024-2025 | Watchman Flx |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $68.78 | 2019 | |
| Digirad Health, INC | $49.59 | 2022 | |
| Tactile Systems Technology INC | $45.06 | 2023-2024 | Flexitouch Plus, Entre Plus |
| Alnylam Pharmaceuticals INC. | $42.86 | 2025 | Amvuttra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.80 | 2022 | |
| Surmodics, INC. | $38.60 | 2023 | Pounce Thrombectomy, Pounce Venous Thrombectomy System, Sublime Radial Access 018 Rx Pta Dilatation Catheter |
| Baxter Healthcare | $35.35 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Dexcom, INC. | $32.50 | 2024 | Dexcom G7 Gss (161) |
| Edwards Lifesciences Corporation | $28.34 | 2023 | Pascal |
| Gilead Sciences, INC. | $25.61 | 2019 | |
| Itamar Medical INC | $24.40 | 2023 | Watchpatone |
| Actelion Pharmaceuticals US, INC. | $23.30 | 2025 | Opsynvi, Opsumit, Uptravi |
| Vifor Pharma, INC. | $22.63 | 2019 | |
| Medtronic Vascular, INC. | $21.04 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $20.12 | 2024 | |
| Exact Sciences Corporation | $19.88 | 2024 | Cologuard Collection Kit |
| Cvrx, INC. | $18.37 | 2022 | |
| Philips North America LLC | $16.85 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $15.49 | 2019 | |
| Abbvie INC. | $14.57 | 2021 | |
| Lundbeck LLC | $14.08 | 2019 | |
| Kestra Medical Technology Services, INC. | $14.04 | 2025 | Assure Wcd |
| Vivaquant INC, Dba Rhythm Express | $14.00 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Marshall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.